DIAGNOSIS OF MYELOMONOCYTIC AND MACROPHAGE NEOPLASMS IN ROUTINELY PROCESSED TISSUE BIOPSIES WITH MONOCLONAL-ANTIBODY KP1 AMERICAN JOURNAL OF PATHOLOGY Warnke, R. A., Pulford, K. A., PALLESEN, G., Ralfkiaer, E., Brown, D. C., Gatter, K. C., Mason, D. Y. 1989; 135 (6): 1089-1095

Abstract

A new monoclonal antibody, KP1, against the CD68 antigen, which labels macrophages and other members of the mononuclear phagocyte lineage in routinely processed tissue sections, has been used to stain a range of lymphoid, histiocytic, and myelomonocytic proliferations. All 20 neoplasms of myeloid, myelomonocytic, and presumed macrophage derivation reacted with antibody KP1. None of the 22 cases of T cell neoplasia had positive reactions. Although 14 of 41 B lineage lymphomas and leukaemias were stained by antibody KP1, staining was usually confined to small dots of reactivity, in contrast to the strong and extensive cytoplasmic staining seen in the neoplasms of myeloid and macrophage/monocyte origin. Furthermore, positive B cell neoplasms were almost all small cell proliferations, which are unlikely to be confused with myelomonocytic malignancies. It was concluded that antibody KP1 is a valuable addition to a panel of monoclonal antibodies for phenotyping lymphomas, particularly in routinely fixed tissues. It should assist the pathologist in the recognition of extramedullary presentation of leukaemia, aid in the diagnosis of suspected cases of true histiocytic neoplasia, and allow for quantitation of macrophages infiltrating lymphomas and other solid tumors.

View details for Web of Science ID A1989CE32300013

View details for PubMedID 2688430